A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer

This study is not yet open for participant recruitment.
Verified December 2012 by Severance Hospital
Sponsor:
Information provided by (Responsible Party):
Byeong Woo Park, Severance Hospital
ClinicalTrials.gov Identifier:
NCT01752686
First received: September 26, 2012
Last updated: December 21, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)